stata v 13 se (STATA Corporation)
99
Structured Review
STATA Corporation
stata v 13 se
Stata V 13 Se, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 33813 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+v+13/STATA+13%2E0/pm40514238-112-18-18
Average 99 stars, based on 33813 article reviews
Stata V 13 Se, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 33813 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+v+13/STATA+13%2E0/pm40514238-112-18-18
Average 99 stars, based on 33813 article reviews
stata v 13 se - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: Resistant Atherosclerosis Article Snippet: Data were analyzed using IBM SPSS Statistics v. 23 (IBM Inc) and Article Title: Risk perception and vulnerabilities for HIV/AIDS among transgender women in Brazil: mixed methods approach. Article Snippet: Transgender women (TW) are a key population in the dynamics of human immunodeficiency virus (HIV) dissemination, although little is known about their perceptions of HIV risk.. In this embedded, nested, mixed-methods study, we assessed factors associated with condomless sexual intercourse among TW and explored their risk perceptions and vulnerabilities regarding HIV exposure.. The first phase involved a cross-sectional study, followed by qualitative interviews. Article Title: Potential benefit from the implementation of the Kaiser Permanente neonatal early-onset sepsis calculator on clinical management of neonates with presumed sepsis. Article Snippet: To assess the potential benefit from the implementation of the Kaiser Permanente early-onset sepsis calculator (EOS-C), in terms of antibiotic use and requested laboratory tests, in a network of neonatal intensive care units (NICUs) in Greece, and to determine the incidence of early-onset sepsis (EOS) in Greek NICUs, a prospective surveillance study was conducted in 7 NICUs between April 2018 and June 2019.. Data were collected for all newborns ≥ 34 weeks’ gestation receiving empiric antibiotic therapy within the first 3 days of life.. The number of live births and positive blood or cerebrospinal fluid cultures within the first 3 days of life were used for calculation of EOS incidence. |